A comprehensive view of European Medicines Agency. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

CHMP recommends EU approval of Roche’s Alecensa monotherapy as the first adjuvant treatment for resected ALK-positive early-stage lung cancer; about half of people living with early-stage NSCLC experiencing disease recurrence or death following surgery
Published: April 26, 2024 by F. Hoffmann-La Roche Ltd. (Roche)
European Medicines Agency finds no link between popular GLP-1 receptor agonists and suicidal thoughts after eight-month investigation; study corroborates earlier findings from the FDA
Published: April 15, 2024 by FiercePharma
European Medicines Agency delays decision on Biogen and Eisai's Alzheimer's drug lecanemab due to procedural implications from an EU court ruling; the delay is unrelated to the marketing authorization application submitted for lecanemab
Published: March 26, 2024 by Zack's Commentary
Novo Nordisk's diabetes treatment Awiqli gets positive CHMP opinion for adult use in Europe; the once-weekly basal insulin icodec shows improved blood sugar reduction and safety profile, becoming a potential preferred treatment for type 2 diabetes
Published: March 26, 2024 by Contify Life Science News
Janssen-Cilag seeks approval from the European Medicines Agency for the extension of DARZALEX regimen in multiple myeloma treatment, supported by data from the Phase 3 PERSEUS study that showed a significant reduction in disease progression or death risk
Published: March 06, 2024 by Janssen Pharmaceutical Companies

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count